Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Comment on: LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.

Franci G, Dell'Aversana C, Stelitano D, Rinaldi M, Altucci L.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(1):1-2. doi: 10.26355/eurrev_201901_16739. No abstract available.

PMID:
30657539
2.

I BET on anti-FGFR to fight cancer resistance.

Benedetti R, Altucci L.

EMBO Mol Med. 2019 Jan 4. pii: e10116. doi: 10.15252/emmm.201810116. [Epub ahead of print] No abstract available.

3.

Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer.

Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G.

Oncotarget. 2018 Oct 30;9(85):35600. doi: 10.18632/oncotarget.26305. eCollection 2018 Oct 30.

4.

Structure-activity relationships, biological evaluation and structural studies of novel pyrrolonaphthoxazepines as antitumor agents.

Brindisi M, Ulivieri C, Alfano G, Gemma S, de Asís Balaguer F, Khan T, Grillo A, Chemi G, Menchon G, Prota AE, Olieric N, Lucena-Agell D, Barasoain I, Diaz JF, Nebbioso A, Conte M, Lopresti L, Magnano S, Amet R, Kinsella P, Zisterer DM, Ibrahim O, O'Sullivan J, Morbidelli L, Spaccapelo R, Baldari C, Butini S, Novellino E, Campiani G, Altucci L, Steinmetz MO, Brogi S.

Eur J Med Chem. 2019 Jan 15;162:290-320. doi: 10.1016/j.ejmech.2018.11.004. Epub 2018 Nov 3.

PMID:
30448418
5.

Biological interactions of biocompatible and water-dispersed MoS2 nanosheets with bacteria and human cells.

Kaur J, Singh M, Dell'Aversana C, Benedetti R, Giardina P, Rossi M, Valadan M, Vergara A, Cutarelli A, Montone AMI, Altucci L, Corrado F, Nebbioso A, Altucci C.

Sci Rep. 2018 Nov 6;8(1):16386. doi: 10.1038/s41598-018-34679-y.

6.

3-Chloro-N'-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy.

Sarno F, Papulino C, Franci G, Andersen JH, Cautain B, Melardo C, Altucci L, Nebbioso A.

Front Pharmacol. 2018 Sep 7;9:1006. doi: 10.3389/fphar.2018.01006. eCollection 2018.

7.

Sonoporation by microbubbles as gene therapy approach against liver cancer.

Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G.

Oncotarget. 2018 Aug 14;9(63):32182-32190. doi: 10.18632/oncotarget.25875. eCollection 2018 Aug 14. Erratum in: Oncotarget. 2018 Oct 30;9(85):35600.

8.

Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase.

Franci G, Folliero V, Cammarota M, Zannella C, Sarno F, Schiraldi C, de Lera AR, Altucci L, Galdiero M.

Sci Rep. 2018 Sep 3;8(1):13117. doi: 10.1038/s41598-018-31135-9.

9.

Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies.

Brindisi M, Senger J, Cavella C, Grillo A, Chemi G, Gemma S, Cucinella DM, Lamponi S, Sarno F, Iside C, Nebbioso A, Novellino E, Shaik TB, Romier C, Herp D, Jung M, Butini S, Campiani G, Altucci L, Brogi S.

Eur J Med Chem. 2018 Sep 5;157:127-138. doi: 10.1016/j.ejmech.2018.07.069. Epub 2018 Jul 31.

PMID:
30092367
10.

Forskolin Sensitizes Human Acute Myeloid Leukemia Cells to H3K27me2/3 Demethylases GSKJ4 Inhibitor via Protein Kinase A.

Illiano M, Conte M, Sapio L, Nebbioso A, Spina A, Altucci L, Naviglio S.

Front Pharmacol. 2018 Jul 20;9:792. doi: 10.3389/fphar.2018.00792. eCollection 2018.

11.

Synthesis and Biological Evaluation of Tripartin, a Putative KDM4 Natural Product Inhibitor, and 1-Dichloromethylinden-1-ol Analogues.

Guillade L, Sarno F, Tarhonskaya H, Nebbioso A, Alvarez S, Kawamura A, Schofield CJ, Altucci L, de Lera ÁR.

ChemMedChem. 2018 Sep 19;13(18):1949-1956. doi: 10.1002/cmdc.201800377. Epub 2018 Aug 21.

PMID:
30047603
12.

Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case report.

Rosati G, Del Gaudio N, Scarano E, Cifarelli RA, Altucci L, Bilancia D.

Medicine (Baltimore). 2018 Jun;97(25):e11178. doi: 10.1097/MD.0000000000011178.

13.

Cancer epigenetics: Moving forward.

Nebbioso A, Tambaro FP, Dell'Aversana C, Altucci L.

PLoS Genet. 2018 Jun 7;14(6):e1007362. doi: 10.1371/journal.pgen.1007362. eCollection 2018 Jun. Review.

14.

Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia.

Singh AA, Petraglia F, Nebbioso A, Yi G, Conte M, Valente S, Mandoli A, Scisciola L, Lindeboom R, Kerstens H, Janssen-Megens EM, Pourfarzad F, Habibi E, Berentsen K, Kim B, Logie C, Heath S, Wierenga ATJ, Clarke L, Flicek P, Jansen JH, Kuijpers T, Yaspo ML, Valle VD, Bernard O, Gut I, Vellenga E, Stunnenberg HG, Mai A, Altucci L, Martens JHA.

Oncotarget. 2018 May 22;9(39):25647-25660. doi: 10.18632/oncotarget.25429. eCollection 2018 May 22.

15.

Combined HAT/EZH2 modulation leads to cancer-selective cell death.

Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-Megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L.

Oncotarget. 2018 May 22;9(39):25630-25646. doi: 10.18632/oncotarget.25428. eCollection 2018 May 22.

16.

Pro-inflammatory cytokines activate hypoxia-inducible factor 3α via epigenetic changes in mesenchymal stromal/stem cells.

Cuomo F, Coppola A, Botti C, Maione C, Forte A, Scisciola L, Liguori G, Caiafa I, Ursini MV, Galderisi U, Cipollaro M, Altucci L, Cobellis G.

Sci Rep. 2018 Apr 11;8(1):5842. doi: 10.1038/s41598-018-24221-5.

17.

RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of Cancer.

Carafa V, Nebbioso A, Cuomo F, Rotili D, Cobellis G, Bontempo P, Baldi A, Spugnini EP, Citro G, Chambery A, Russo R, Ruvo M, Ciana P, Maravigna L, Shaik J, Radaelli E, De Antonellis P, Tarantino D, Pirolli A, Ragno R, Zollo M, Stunnenberg HG, Mai A, Altucci L.

Clin Cancer Res. 2018 Jun 15;24(12):2886-2900. doi: 10.1158/1078-0432.CCR-17-3081. Epub 2018 Mar 13.

PMID:
29535128
18.

HDAC inhibitors as epigenetic regulators for cancer immunotherapy.

Conte M, De Palma R, Altucci L.

Int J Biochem Cell Biol. 2018 May;98:65-74. doi: 10.1016/j.biocel.2018.03.004. Epub 2018 Mar 10. Review.

PMID:
29535070
19.

The HDAC inhibitor SAHA regulates CBX2 stability via a SUMO-triggered ubiquitin-mediated pathway in leukemia.

Di Costanzo A, Del Gaudio N, Conte L, Dell'Aversana C, Vermeulen M, de Thé H, Migliaccio A, Nebbioso A, Altucci L.

Oncogene. 2018 May;37(19):2559-2572. doi: 10.1038/s41388-018-0143-1. Epub 2018 Feb 22.

20.

Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation.

Bilancio A, Bontempo P, Di Donato M, Conte M, Giovannelli P, Altucci L, Migliaccio A, Castoria G.

Oncotarget. 2017 Dec 18;8(70):115620-115631. doi: 10.18632/oncotarget.23360. eCollection 2017 Dec 29.

21.

Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FK, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D'Angiolella V, Dawson TM, Dawson VL, De Laurenzi V, De Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, Di Daniele N, Di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, El-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, Vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G.

Cell Death Differ. 2018 Mar;25(3):486-541. doi: 10.1038/s41418-017-0012-4. Epub 2018 Jan 23. Review.

22.

Designing Dual Transglutaminase 2/Histone Deacetylase Inhibitors Effective at Halting Neuronal Death.

Basso M, Chen HH, Tripathy D, Conte M, Apperley KYP, De Simone A, Keillor JW, Ratan R, Nebbioso A, Sarno F, Altucci L, Milelli A.

ChemMedChem. 2018 Feb 6;13(3):227-230. doi: 10.1002/cmdc.201700601. Epub 2018 Jan 18.

PMID:
29286587
23.

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.

Dell'Aversana C, Giorgio C, D'Amato L, Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V, Ingenito C, Martens JHA, Pallavicini I, Minucci S, Carissimo A, Stunnenberg HG, Altucci L.

Leukemia. 2018 Feb;32(2):573. doi: 10.1038/leu.2017.310. Epub 2017 Dec 22.

24.

Breast Cancer Vaccines: New Insights.

Benedetti R, Dell'Aversana C, Giorgio C, Astorri R, Altucci L.

Front Endocrinol (Lausanne). 2017 Oct 13;8:270. doi: 10.3389/fendo.2017.00270. eCollection 2017. Review.

25.

Time-resolved analysis of DNA-protein interactions in living cells by UV laser pulses.

Nebbioso A, Benedetti R, Conte M, Carafa V, De Bellis F, Shaik J, Matarese F, Della Ventura B, Gesuele F, Velotta R, Martens JHA, Stunnenberg HG, Altucci C, Altucci L.

Sci Rep. 2017 Sep 15;7(1):11725. doi: 10.1038/s41598-017-12010-5.

26.

A key HDAC6 dependency of ARID1A-mutated ovarian cancer.

Altucci L.

Nat Cell Biol. 2017 Jul 28;19(8):889-890. doi: 10.1038/ncb3588.

PMID:
28752851
27.

Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone Acetyltransferase.

Madia VN, Benedetti R, Barreca ML, Ngo L, Pescatori L, Messore A, Pupo G, Saccoliti F, Valente S, Mai A, Scipione L, Zheng YG, Tintori C, Botta M, Cecchetti V, Altucci L, Di Santo R, Costi R.

ChemMedChem. 2017 Aug 22;12(16):1359-1368. doi: 10.1002/cmdc.201700040. Epub 2017 Apr 12.

PMID:
28346821
28.

Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure-Activity Relationship, X-ray Crystal Structure, and Anticancer Activity.

Moniot S, Forgione M, Lucidi A, Hailu GS, Nebbioso A, Carafa V, Baratta F, Altucci L, Giacché N, Passeri D, Pellicciari R, Mai A, Steegborn C, Rotili D.

J Med Chem. 2017 Mar 23;60(6):2344-2360. doi: 10.1021/acs.jmedchem.6b01609. Epub 2017 Mar 14.

PMID:
28240897
29.

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis.

Dell'Aversana C, Giorgio C, D'Amato L, Lania G, Matarese F, Saeed S, Di Costanzo A, Belsito Petrizzi V, Ingenito C, Martens JHA, Pallavicini I, Minucci S, Carissimo A, Stunnenberg HG, Altucci L.

Leukemia. 2017 Nov;31(11):2315-2325. doi: 10.1038/leu.2017.64. Epub 2017 Feb 20. Erratum in: Leukemia. 2017 Dec 22;:.

30.

Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune Systems.

Schuyler RP, Merkel A, Raineri E, Altucci L, Vellenga E, Martens JHA, Pourfarzad F, Kuijpers TW, Burden F, Farrow S, Downes K, Ouwehand WH, Clarke L, Datta A, Lowy E, Flicek P, Frontini M, Stunnenberg HG, Martín-Subero JI, Gut I, Heath S.

Cell Rep. 2016 Nov 15;17(8):2101-2111. doi: 10.1016/j.celrep.2016.10.054.

31.

The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.

Mandoli A, Singh AA, Prange KHM, Tijchon E, Oerlemans M, Dirks R, Ter Huurne M, Wierenga ATJ, Janssen-Megens EM, Berentsen K, Sharifi N, Kim B, Matarese F, Nguyen LN, Hubner NC, Rao NA, van den Akker E, Altucci L, Vellenga E, Stunnenberg HG, Martens JHA.

Cell Rep. 2016 Nov 15;17(8):2087-2100. doi: 10.1016/j.celrep.2016.08.082.

32.

MicroRNA Expression Profiling Using Agilent One-Color Microarray.

Dell'Aversana C, Giorgio C, Altucci L.

Methods Mol Biol. 2017;1509:169-183.

PMID:
27826927
33.

Identification and characterization of PKF118-310 as a KDM4A inhibitor.

Franci G, Sarno F, Nebbioso A, Altucci L.

Epigenetics. 2017 Mar 4;12(3):198-205. doi: 10.1080/15592294.2016.1249089. Epub 2016 Oct 21.

34.

MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.

Piegari E, Russo R, Cappetta D, Esposito G, Urbanek K, Dell'Aversana C, Altucci L, Berrino L, Rossi F, De Angelis A.

Oncotarget. 2016 Sep 20;7(38):62312-62326. doi: 10.18632/oncotarget.11468.

35.

Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies.

Brindisi M, Cavella C, Brogi S, Nebbioso A, Senger J, Maramai S, Ciotta A, Iside C, Butini S, Lamponi S, Novellino E, Altucci L, Jung M, Campiani G, Gemma S.

Future Med Chem. 2016 Sep;8(13):1573-87. doi: 10.4155/fmc-2016-0068. Epub 2016 Aug 24.

PMID:
27556815
36.

c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.

Nebbioso A, Carafa V, Conte M, Tambaro FP, Abbondanza C, Martens J, Nees M, Benedetti R, Pallavicini I, Minucci S, Garcia-Manero G, Iovino F, Lania G, Ingenito C, Belsito Petrizzi V, Stunnenberg HG, Altucci L.

Clin Cancer Res. 2017 May 15;23(10):2542-2555. doi: 10.1158/1078-0432.CCR-15-2388. Epub 2016 Jun 29.

37.

Sirtuin functions and modulation: from chemistry to the clinic.

Carafa V, Rotili D, Forgione M, Cuomo F, Serretiello E, Hailu GS, Jarho E, Lahtela-Kakkonen M, Mai A, Altucci L.

Clin Epigenetics. 2016 May 25;8:61. doi: 10.1186/s13148-016-0224-3. eCollection 2016. Review.

38.

Epigenetic drugs: from chemistry via biology to medicine and back.

Altucci L, Rots MG.

Clin Epigenetics. 2016 May 23;8:56. doi: 10.1186/s13148-016-0222-5. eCollection 2016. No abstract available.

39.

"Stockpile" of Slight Transcriptomic Changes Determines the Indirect Genotoxicity of Low-Dose BPA in Thyroid Cells.

Porreca I, Ulloa Severino L, D'Angelo F, Cuomo D, Ceccarelli M, Altucci L, Amendola E, Nebbioso A, Mallardo M, De Felice M, Ambrosino C.

PLoS One. 2016 Mar 16;11(3):e0151618. doi: 10.1371/journal.pone.0151618. eCollection 2016.

40.

1,4-Dihydropyridines Active on the SIRT1/AMPK Pathway Ameliorate Skin Repair and Mitochondrial Function and Exhibit Inhibition of Proliferation in Cancer Cells.

Valente S, Mellini P, Spallotta F, Carafa V, Nebbioso A, Polletta L, Carnevale I, Saladini S, Trisciuoglio D, Gabellini C, Tardugno M, Zwergel C, Cencioni C, Atlante S, Moniot S, Steegborn C, Budriesi R, Tafani M, Del Bufalo D, Altucci L, Gaetano C, Mai A.

J Med Chem. 2016 Feb 25;59(4):1471-91. doi: 10.1021/acs.jmedchem.5b01117. Epub 2016 Jan 5.

PMID:
26689352
41.

Secretome profiling of cytokines and growth factors reveals that neuro-glial differentiation is associated with the down-regulation of Chemokine Ligand 2 (MCP-1/CCL2) in amniotic fluid derived-mesenchymal progenitor cells.

Miceli M, Dell'Aversana C, Russo R, Rega C, Cupelli L, Ruvo M, Altucci L, Chambery A.

Proteomics. 2016 Feb;16(4):674-88. doi: 10.1002/pmic.201500223. Epub 2016 Jan 18.

PMID:
26604074
42.

Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives.

Franci G, Manfroni G, Cannalire R, Felicetti T, Tabarrini O, Salvato A, Barreca ML, Altucci L, Cecchetti V.

Cell Prolif. 2015 Dec;48(6):705-17. doi: 10.1111/cpr.12224.

PMID:
26597381
43.

D-ribose-glycation of insulin prevents amyloid aggregation and produces cytotoxic adducts.

Iannuzzi C, Borriello M, Carafa V, Altucci L, Vitiello M, Balestrieri ML, Ricci G, Irace G, Sirangelo I.

Biochim Biophys Acta. 2016 Jan;1862(1):93-104. doi: 10.1016/j.bbadis.2015.10.021. Epub 2015 Oct 28. No abstract available.

44.

Epigenetic-based therapy: From single- to multi-target approaches.

Benedetti R, Conte M, Iside C, Altucci L.

Int J Biochem Cell Biol. 2015 Dec;69:121-31. doi: 10.1016/j.biocel.2015.10.016. Epub 2015 Oct 19. Review.

PMID:
26494003
45.

Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.

Nebbioso A, Benedetti R, Conte M, Iside C, Altucci L.

Expert Opin Ther Targets. 2015;19(9):1187-202. doi: 10.1517/14728222.2015.1051728. Epub 2015 May 30. Review.

PMID:
26028314
46.

Corrigendum to "SIRT1 inhibition affects angiogenic properties of human MSCs".

Botti C, Caiafa I, Coppola A, Cuomo F, Miceli M, Altucci L, Cobellis G.

Biomed Res Int. 2015;2015:132086. doi: 10.1155/2015/132086. Epub 2015 Mar 25. No abstract available.

47.

Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin.

Basile A, Rigano D, Loppi S, Di Santi A, Nebbioso A, Sorbo S, Conte B, Paoli L, De Ruberto F, Molinari AM, Altucci L, Bontempo P.

Int J Mol Sci. 2015 Apr 9;16(4):7861-75. doi: 10.3390/ijms16047861.

48.

Glycation of Wild-Type Apomyoglobin Induces Formation of Highly Cytotoxic Oligomeric Species.

Iannuzzi C, Carafa V, Altucci L, Irace G, Borriello M, Vinciguerra R, Sirangelo I.

J Cell Physiol. 2015 Nov;230(11):2807-20. doi: 10.1002/jcp.25011.

PMID:
25846844
49.

Synthesis of 7-alkylidene-7,12-dihydroindolo[3,2-d]benzazepine-6-(5H)-ones (7-alkylidene-paullones) by N-cyclization-oxidative Heck cascade and characterization as sirtuin modulators.

Denis JG, Franci G, Altucci L, Aurrecoechea JM, de Lera ÁR, Álvarez R.

Org Biomol Chem. 2015 Mar 7;13(9):2800-10. doi: 10.1039/c4ob02493a.

PMID:
25604354
50.

ARHGEF3 controls HDACi-induced differentiation via RhoA-dependent pathways in acute myeloid leukemias.

D'Amato L, Dell'Aversana C, Conte M, Ciotta A, Scisciola L, Carissimo A, Nebbioso A, Altucci L.

Epigenetics. 2015;10(1):6-18. doi: 10.4161/15592294.2014.988035. Epub 2015 Jan 27.

Supplemental Content

Loading ...
Support Center